IDEXX LABORATORIES INC /DE Fair Value of Assets Acquired
IDEXX LABORATORIES INC /DE (IDXX) reported Fair Value of Assets Acquired of $400.00 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-04-25.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2014-10-24
- IDEXX LABORATORIES INC /DE fair value of assets acquired for the quarter ending 2014-03-31 was $400.00K.
- IDEXX LABORATORIES INC /DE fair value of assets acquired for the quarter ending 2013-09-30 was -$1.60M.
- IDEXX LABORATORIES INC /DE fair value of assets acquired for fiscal 2012 was $7.90M, a 182.14% increase from fiscal 2011.
- IDEXX LABORATORIES INC /DE fair value of assets acquired for fiscal 2011 was $2.80M.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 6 month | Fair Value of Assets Acquired 9 month | Fair Value of Assets Acquired 12 month |
|---|---|---|---|---|
| 2014-03-31 | $400.00K 10-Q · filed 2014-04-25 | |||
| 2013-09-30 | -$1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $900.00K 10-Q · filed 2014-10-24 | ||
| 2013-06-30 | $2.50M 10-Q · filed 2014-07-25 | |||
| 2012-12-31 | $7.90M 10-K · filed 2014-02-18 | |||
| 2011-12-31 | $2.80M 10-K · filed 2014-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |